Bioniche Pharma Holdings Ltd.

In recent years, big pharma has talked about the patent cliff and strategies to address lost revenues as blockbuster drugs went off-patent in the U.S. and Europe. But with the turn of the calendar pag

The New Year’s Day announcement that Jeremy Levin, a former senior Bristol-Myers Squibb Co. executive would replace Shlomo Yanai, the current CEO of Teva Pharmaceutical Industries Ltd., in May i

Relieving pain and slowing OA progression in weight-bearing joints 555 D'Onofrio Drive Suite 102 Madison, WI 53719 Phone: (608) 213-8246 Web Site: www.flexbio.com Contact: Sal Braico, President & CEO

A look at financing, M&A, and alliance activity July–September 2010 In this issue, we present another installment of our quarterly review of pharmaceutical/biotechnology dealmaking – for the third qua